JAMA sees ghost authors
The June 5 Journal of American Medical Association devoted to peer review issues, includes article on honorary and ghost authorship. Graham Mowatt, University of Aberdeen, et al., examined 362 reviews published in The Cochrane Library and found 9% had evidence of ghost authorship and 39% had evidence of honorary authorship. PhRMA is developing guidelines on disclosing authorship (1"The Pink Sheet" May 13, p. 20)...
You may also be interested in...
Manuscript writers and statisticians provided by drug sponsors to help present results from a clinical trial will be "recognized appropriately" as contributors to publications of the data, according to a draft policy paper on the ethics of clinical trials under development by the Pharmaceutical Research & Manufacturers of America
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.